| | |
| Clinical data | |
|---|---|
| Other names | 1-Cyclopropylmethylclonazepam, Kloniprazepam, 2-Chloro-7'-nitroprazepam |
| Drug class | Benzodiazepines |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H16ClN3O3 |
| Molar mass | 369.81 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cloniprazepam is a benzodiazepine derivative and a prodrug of clonazepam, 7-aminoclonazepam, and other metabolites. [1] [2]
Some of the minor metabolites include 3-hydroxyclonazepam and 6-hydroxyclonazepam, 3-hydroxycloniprazepam and ketocloniprazepam with ketone group formed where 3-hydroxy group was. [1]
It is a designer drug and an NPS (short for "new psychoactive substance"). [1] At the end of 2017, cloniprazepam was an uncontrolled substance in most of the countries.